CHOD/BVAM CHEMOTHERAPY AND WHOLE-BRAIN RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

PURPOSE: To assess the efficacy and toxicity of chemotherapy consisting of cyclophosphamide, doxorubicin (Adriamycin), vincristine, and dexamethasone (CHOD) plus bis-chloronitrosourea (BCNU), cytosine arabinoside, and methotrexate (BVAM) followed by whole-brain irradiation (WBRT) for patients with p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Radiat Oncol Biol Phys
Main Authors: Laack, Nadia N., O’Neill, Brian Patrick, Ballman, Karla V., O’Fallon, Judith Rich, Carrero, Xiomara W., Kurtin, Paul J., Scheithauer, Bernd W., Brown, Paul D., Habermann, Thomas M., Colgan, Joseph P., Gilbert, Mark R., Hawkins, Roland B., Morton, Roscoe F., Windschitl, Harry E., Fitch, Tom R., Pajon, Eduardo R.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335722/
https://ncbi.nlm.nih.gov/pubmed/20800387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2010.06.002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares